Global Exosomes Market Size Study By Workflow (Downstream Analysis, and Isolation Methods), By Biomolecule Type (mRNA, Non-Coding RNAs, DNA Fragments, Lipids, Proteins/Peptides), By Application (Infectious Diseases, Neurodegenerative Diseases, Cancer, and Cardiovascular Diseases) and By Regional Forecasts, 2018-2025

July 2018 | 120 pages | ID: GF46C5FE641EN
Bizwit Research & Consulting LLP

Abstracts

Global Exosomes Market to reach USD XXX million by 2025.

Global Exosomes Market valued approximately USD XXX million in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets are small companies flooding the marketplace, granular & bottom-up efforts made by researchers in the field, soaring number of research grants & projects by various research organizations and development of novel platforms & advanced technologies. Exosomes are defined as extracellular vesicles which are discharged from cells upon fusion of an intermediary endocytic compartment, the multivesicular body, with the plasma membrane.

The regional analysis of Global Exosomes Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North American region is the leading region across the world in terms of market share. Whereas, owing to countries viz. India, Indonesia, China, and Japan, the Asia Pacific region is expected to exhibit higher growth rate / CAGR over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Workflow:

• Downstream Analysis
• Protein analysis using Blotting & ELISA
• Proteomic analysis using Mass Spectrometry
• Cell Surface Marker Analysis using Flow Cytometry
• RNA analysis with NGS & PCR
• Isolation Methods
• Ultracentrifugation
• Precipitation
• Immunocapture on beads
• Filtration
• Other

By Biomolecule Type:

• Lipids
• Non-Coding RNAs
• DNA fragments
• Proteins/Peptides
• mRNA

By Application:

• Infectious Diseases
• Neurodegenerative Diseases
• Cancer
• Cardiovascular Diseases
• Others

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Danaher, Fujifilm, Illumina, Inc., Lonza, Qiagen, MBL International Corporation, Takara Bio Company, Malvern Instruments Ltd., Thermo Fisher Scientific, Inc., Miltenyi Biotec, and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.

Target Audience of the Exosomes Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL EXOSOMES MARKET DEFINITION & SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL EXOSOMES MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL EXOSOMES MARKET BY WORKFLOW

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Exosomes Market, Sub Segment Analysis
  5.3.1. Downstream Analysis
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      5.3.1.3.1. Protein analysis using Blotting & ELISA
      5.3.1.3.2. Proteomic analysis using Mass Spectrometry
      5.3.1.3.3. Cell Surface Marker Analysis using Flow Cytometry
      5.3.1.3.4. RNA analysis with NGS & PCR
  5.3.2. Isolation Methods
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      5.3.2.3.1. Ultracentrifugation
      5.3.2.3.2. Precipitation
      5.3.2.3.3. Immunocapture on beads
      5.3.2.3.4. Filtration
      5.3.2.3.5. Others

CHAPTER 6. GLOBAL EXOSOMES MARKET BY BIOMOLECULE TYPE

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Exosomes Market, Sub Segment Analysis
  6.3.1. Lipids
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Non-Coding RNAs
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.3. DNA fragments
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.4. Proteins/Peptides
    6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.5. mRNA
    6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL EXOSOMES MARKET BY APPLICATION

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Exosomes Market, Sub Segment Analysis
  7.3.1. Infectious Diseases
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Neurodegenerative Diseases
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.3. Cancer
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.4. Cardiovascular Diseases
    7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.5. Others
    7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL EXOSOMES MARKET, REGIONAL ANALYSIS

8.1. Exosomes Market, Regional Market Snapshot (2015-2025)
8.2. North America Exosomes Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Exosomes Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Exosomes Market Snapshot
  8.4.1. China Exosomes Market Size Estimates & Forecasts, 2015-2025 (USD Billion)
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Exosomes Market Snapshot
  8.5.1. Brazil
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.5.2. Mexico
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
  8.6.1. South America
    8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.6.2. Middle East and Africa
    8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.2. Workflow breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.3. Biomolecule Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.4. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. Danaher
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. Fujifilm
  9.3.3. Illumina, Inc.
  9.3.4. Lonza
  9.3.5. Qiagen
  9.3.6. MBL International Corporation
  9.3.7. Takara Bio Company
  9.3.8. Malvern Instruments Ltd.
  9.3.9. Thermo Fisher Scientific, Inc.
  9.3.10. Miltenyi Biotec